<?xml version="1.0" encoding="UTF-8"?>
<ref id="B22">
 <label>22</label>
 <mixed-citation publication-type="journal">
  <person-group person-group-type="author">
   <name>
    <surname>Cunningham</surname>
    <given-names>D</given-names>
   </name>
   <name>
    <surname>Chau</surname>
    <given-names>I</given-names>
   </name>
   <name>
    <surname>Stocken</surname>
    <given-names>DD</given-names>
   </name>
   <name>
    <surname>Valle</surname>
    <given-names>JW</given-names>
   </name>
   <name>
    <surname>Smith</surname>
    <given-names>D</given-names>
   </name>
   <name>
    <surname>Steward</surname>
    <given-names>W</given-names>
   </name>
   <etal/>
  </person-group>. 
  <article-title>Phase III Randomized Comparison of Gemcitabine Versus Gemcitabine Plus Capecitabine in Patients With Advanced Pancreatic Cancer</article-title>. 
  <source>J Clin Oncol</source> (
  <year>2009</year>) 
  <volume>27</volume>:
  <page-range>5513–8</page-range>.  
  <pub-id pub-id-type="doi">10.1200/JCO.2009.24.2446</pub-id>
 </mixed-citation>
</ref>
